in

Covid-19 News: We bring you the summary of the most relevant

Covid-19 news

We bring you the summary of the most relevant:

Tuesday June 29

Moderna vaccine is effective against 7 variants of SARS-CoV-2

Moderna’s vaccine is effective and protects against infection from at least seven variants of the SARS-CoV-2 virus, including those that emerged in India, a new study detailed. In a statement it was reported that the vaccine, developed with mRNA technology, is effective in neutralizing sera from vaccinated individuals in vitro. The tests showed the effectiveness of the vaccine for the variants:

The Beta variant B.1.351, first identified in South Africa Three lineage variants of B.1.617, include the Kappa variants B.1.617.1 and Delta B.1.617.2 The Eta variant B.1.525, first identified in Nigeria Variant A.23.1 emerged in Uganda Variant A.VOI.V2 identified in Angola

The delta variant spreads and alarms for its contagion capacity

The Delta variant of the coronavirus spreads across different countries and, with it, concerns about the spread of the pandemic given its high transmission capacity. Faced with this risk, there is confidence in the growing vaccination of populations, although the rate varies from country to country. (.)

The effectiveness of the Russian vaccine is 2.6 times lower against the Delta variant

The effectiveness of the Russian Sputnik V vaccine is 2.6 times lower against the Indian variant of the coronavirus, Denis Logunov, the deputy director of Research at the Gamaleya Center, developer of the preparation, said today. Sputnik V has shown an efficacy of 97.6% in the vaccination campaign of Russians, but the variant that emerged in India, mainly the “Delta” “slightly lowers the activity of the serum,” Logunov said at a press conference. (.)

Monday June 28

Waiting between doses improves AstraZeneca vaccine efficacy

An interval of several months between the first and second doses of the Covid-19 vaccine developed by AstraZeneca / Oxford improves immunity, according to a study published Monday by the University of Oxford. The researchers showed that, far from reducing the effectiveness of the vaccine, an interval of up to 45 weeks between the two doses improves the immune response to the virus. (.)

AstraZeneca tests its vaccine against the Beta variant

The University of Oxford announced this Sunday that it began injecting volunteers with a vaccine developed with the AstraZeneca laboratory against the Beta variant of the coronavirus, initially detected in South Africa. The British university and the Anglo-Swedish laboratory hope to bring together 2,500 volunteers in the UK, South Africa, Brazil and Poland to roll out phases 2 and 3 of this human clinical trial, a statement said. (.)

Confinements in Latin America generate school exclusion

The lack of internet and the limited accessibility to technology in Latin American countries during the confinements by Covid-19 generated in children school exclusion, escapes from home or school and health-related problems, according to a report by the Share Foundation. Red Compartir works to guarantee the right to education for more than 15,000 children in Latin America through its support to seven local entities in Argentina, Chile, Ecuador, Honduras and Nicaragua. (.)

Argentina’s economy contracts more than expected in April

Tennis player Andrea Petkovic will be in the 30th finals of Wimbledon